What do systematic reviews say?

Percutaneous ethanol injection vs radiofrequency ablation

The review found no eligible studies for this question.

• Management of people with early‐ or very early‐stage hepatocellular carcinoma 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Laser ablation vs radiofrequency ablation

The review found no eligible studies for this question.

• Management of people with early‐ or very early‐stage hepatocellular carcinoma 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Transarterial embolisation plus radiofrequency ablation vs radiofrequency ablation

The review found no eligible studies for this question.

• Management of people with early‐ or very early‐stage hepatocellular carcinoma 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Transarterial embolisation plus percutaneous alcohol injection vs percutaneous alcohol injection

The review found no eligible studies for this question.

• Management of people with early‐ or very early‐stage hepatocellular carcinoma 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Surgery vs radiofrequency ablation

The review found no eligible studies for this question.

• Management of people with early‐ or very early‐stage hepatocellular carcinoma 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2… 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

High‐intensity vs moderate‐intensity exercise

• Exercise‐based cardiac rehabilitation in heart transplant recipients 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 16 participants
  Moderate

Exercise vs control

• Exercise for women receiving adjuvant therapy for breast cancer 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 68 participants
  Low

Intervention not reported

The review found no eligible studies for this question.

• Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sulodexide + local treatment vs local treatment

The review found no eligible studies for this question.

• Sulodexide for treating venous leg ulcers 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Vilanterol and fluticasone furoate vs placebo

Vilanterol and fluticasone furoate showed no clear difference in health‐related quality of life compared with placebo (moderate certainty).

• Vilanterol and fluticasone furoate for asthma 2016 · Cochrane Headline outcomes only
  MD 0.3
  2012 participants
  Moderate

Intervention not reported

The review found no eligible studies for this question.

• Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and improve… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Bortezomib vs no bortezomib

• Bortezomib for the treatment of multiple myeloma 2016 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 717 participants
  GRADE not reported

Non‐medical prescribing vs medical prescribing

• Non‐medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  8 studies · 4631 participants
  Moderate

Intervention not reported

The review found no eligible studies for this question.

• Self management interventions for type 2 diabetes in adult people with severe mental illness 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Upper limb exercise training vs No upper limb training

• Upper limb exercise training for COPD 2016 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 126 participants
  Moderate